TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
TCL Archive BCDDP Follow Up To Cost $1.6 Million annually For Five Years Okayed; Limited To 59,000 Women November 3, 1978
TCL Archive Cancer Control Program Guidelines Developed For Payment Of Patient Costs December 21, 1973
TCL Archive Clinical Trials: Data Manager Falsified NSABP Records On 3 Patients, ORI Says February 12, 1999
TCL Archive Two Phase III Trials Show Increase In PFS In Two Distinct Patient Populations June 28, 2013
